Infection with francisella tularensis lvs clpb leads to an altered yet protective immune response

Infection and Immunity

Volumn 81, Issue 6, 2013, Pages 2028-2042

  Barrigan, Lydia M ^a,b   Tuladhar, Shraddha ^b   Brunton, Jason C ^a   Woolard, Matthew D ^c   Chen, Ching ju ^d   Saini, Divey ^d   Frothingham, Richard ^d   Sempowski, Gregory D ^d   Kawula, Thomas H ^a   Frelinger, Jeffrey A ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; GAMMA INTERFERON; INTERLEUKIN 17;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA SEQUENCE; FLUORESCENCE; FRANCISELLA TULARENSIS; IMMUNE EVASION; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; LUNG LAVAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; PROVOCATION TEST; TH17 CELL; TRANSPOSON; TULAREMIA; VACCINATION; WEIGHT REDUCTION;

ANIMALS; BACTERIAL VACCINES; CELL LINE; FRANCISELLA TULARENSIS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES; TULAREMIA; VACCINES, ATTENUATED; VIRULENCE;

EID: 84877814587     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00207-13     Document Type: Article

References (48)

1. Pechous RD, McCarthy TR, Zahrt TC. 2009. Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol. Mol. Biol. Rev. 73:684-711.
2. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285:2763-2773.
3. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM, Jr. 1997. Biological warfare. A historical perspective. JAMA 278:412-417.
4. Alibek K, Handelman S. 1999. Biohazard: the chilling true story of the largest covert biological weapons program in the world, told from the inside by the man who ran it, 1st ed. Random House, New York, NY.
5. Kadzhaev K, Zingmark C, Golovliov I, Bolanowski M, Shen H, Conlan W, Sjostedt A. 2009. Identification of genes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection model. PLoS One 4:e5463. doi:10.1371/journal.pone.0005463.
6. Su J, Yang J, Zhao D, Kawula TH, Banas JA, Zhang JR. 2007. Genomewide identification of Francisella tularensis virulence determinants. Infect. Immun. 75:3089-3101.
7. Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, Monack DM. 2007. In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl. Acad. Sci. U. S. A. 104:6037-6042.
8. Metzger DW, Bakshi CS, Kirimanjeswara G. 2007. Mucosal immunopathogenesis of Francisella tularensis. Ann. N. Y. Acad. Sci. 1105:266-283.
9. Conlan JW, Chen W, Shen H, Webb A, KuoLee R. 2003. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb. Pathog. 34:239-248.
10. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH. 2008. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect. Immun. 76:5843-5852.
11. Bosio CM, Dow SW. 2005. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 175:6792-6801.
12. Hajjar AM, Harvey MD, Shaffer SA, Goodlett DR, Sjostedt A, Edebro H, Forsman M, Bystrom M, Pelletier M, Wilson CB, Miller SI, Skerrett SJ, Ernst RK. 2006. Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect. Immun. 74:6730-6738.
13. Bosio CM, Bielefeldt-Ohmann H, Belisle JT. 2007. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J. Immunol. 178:4538-4547.
14. Chong A, Celli J. 2010. The Francisella intracellular life cycle: toward molecular mechanisms of intracellular survival and proliferation. Front. Microbiol. 1:138. doi:10.3389/fmicb.2010.00138.
15. Yee D, Rhinehart-Jones TR, Elkins KL. 1996. Loss of either CD4+ or CD8+T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol. 157: 5042-5048.
16. Collazo CM, Sher A, Meierovics AI, Elkins KL. 2006. Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replication. Microbes Infect. 8:779-790.
17. Leiby DA, Fortier AH, Crawford RM, Schreiber RD, Nacy CA. 1992. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect. Immun. 60:84-89.
18. Anthony LS, Ghadirian E, Nestel FP, Kongshavn PA. 1989. The requirement for gamma interferon in resistance of mice to experimental tularemia. Microb. Pathog. 7:421-428.
19. Woolard MD, Hensley LL, Kawula TH, Frelinger JA. 2008. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect. Immun. 76:2651-2659.
20. Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J, Guglani L, Alcorn JF, Strawbridge H, Park SM, Onishi R, Nyugen N, Walter MJ, Pociask D, Randall TD, Gaffen SL, Iwakura Y, Kolls JK, Khader SA. 2009. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31:799-810.
21. Markel G, Bar-Haim E, Zahavy E, Cohen H, Cohen O, Shafferman A, Velan B. 2010. The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis. PLoS One 5:e11176. doi:10.1371/journal.pone.0011176.
22. Nano FE, Zhang N, Cowley SC, Klose KE, Cheung KK, Roberts MJ, Ludu JS, Letendre GW, Meierovics AI, Stephens G, Elkins KL. 2004. A Francisella tularensis pathogenicity island required for intramacrophage growth. J. Bacteriol. 186:6430-6436.
23. Meibom KL, Dubail I, Dupuis M, Barel M, Lenco J, Stulik J, Golovliov I, Sjostedt A, Charbit A. 2008. The heat-shock protein ClpB of Francisella tularensis is involved in stress tolerance and is required for multiplication in target organs of infected mice. Mol. Microbiol. 67:1384-1401.
24. Conlan JW, Shen H, Golovliov I, Zingmark C, Oyston PC, Chen W, House RV, Sjostedt A. 2010. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization. Vaccine 28:1824-1831.
25. Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W. 2012. BALB/c mice, but not C57BL/6 mice immunized with a DeltaclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses. Vaccine 30: 3634-3645.
26. Chamberlain RE. 1965. Evaluation of live tularemia vaccine prepared in a chemically defined medium. Appl. Microbiol. 13:232-235.
27. LoVullo ED, Molins-Schneekloth CR, Schweizer HP, Pavelka MS, Jr. 2009. Single-copy chromosomal integration systems for Francisella tularensis. Microbiology 155:1152-1163.
28. Woolard MD, Wilson JE, Hensley LL, Jania LA, Kawula TH, Drake JR, Frelinger JA. 2007. Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response. J. Immunol. 178:2065-2074.
29. Porter BB, Harty JT. 2006. The onset of CD8+-T-cell contraction is influenced by the peak of Listeria monocytogenes infection and antigen display. Infect. Immun. 74:1528-1536.
30. Williams MA, Bevan MJ. 2004. Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J. Immunol. 173:6694-6702.
31. Wong P, Pamer EG. 2001. Cutting edge: antigen-independent CD8 T cell proliferation. J. Immunol. 166:5864-5868.
32. Broms JE, Meyer L, Lavander M, Larsson P, Sjostedt A. 2012. DotU and VgrG, core components of type VI secretion systems, are essential for Francisella LVS pathogenicity. PLoS One 7:e34639. doi:10.1371/journal .pone.0034639.
33. Chen W, Shen H, Webb A, KuoLee R, Conlan JW. 2003. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Vaccine 21:3690-3700.
34. Schmitt DM, O'Dee DM, Horzempa J, Carlson PE, Jr, Russo BC, Bales JM, Brown MJ, Nau GJ. 2012. A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacy. PLoS One 7:e31172. doi:10.1371/journal.pone.0031172.
35. Woolard MD, Barrigan LM, Fuller JR, Buntzman AS, Bryan J, Manoil C, Kawula TH, Frelinger JA. 2013. Identification of Francisella novicida mutants that fail to induce prostaglandin E2 synthesis by infected macrophages. Front. Microbiol. 4:16. doi:10.3389/fmicb.2013.00016.
36. Maier TM, Pechous R, Casey M, Zahrt TC, Frank DW. 2006. In vivo Himar1-based transposon mutagenesis of Francisella tularensis. Appl. Environ. Microbiol. 72:1878-1885.
37. Gray CG, Cowley SC, Cheung KK, Nano FE. 2002. The identification of five genetic loci of Francisella novicida associated with intracellular growth. FEMS Microbiol. Lett. 215:53-56.
38. Tempel R, Lai XH, Crosa L, Kozlowicz B, Heffron F. 2006. Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect. Immun. 74:5095-5105.
39. Kalinski P, Vieira PL, Schuitemaker JH, de Jong EC, Kapsenberg ML. 2001. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL- 12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97:3466-3469.
40. Schnurr M, Toy T, Shin A, Wagner M, Cebon J, Maraskovsky E. 2005. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 105:1582-1589.
41. Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D. 2004. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 18:1318-1320.
42. Hunter CA. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5:521-531.
43. Zolkiewski M. 2006. A camel passes through the eye of a needle: protein unfolding activity of Clp ATPases. Mol. Microbiol. 61:1094-1100.
44. Chastanet A, Derre I, Nair S, Msadek T. 2004. clpB, a novel member of the Listeria monocytogenes CtsR regulon, is involved in virulence but not in general stress tolerance. J. Bacteriol. 186:1165-1174.
45. Lourdault K, Cerqueira GM, Wunder EA, Jr, Picardeau M. 2011. Inactivation of clpB in the pathogen Leptospira interrogans reduces virulence and resistance to stress conditions. Infect. Immun. 79:3711-3717.
46. Capestany CA, Tribble GD, Maeda K, Demuth DR, Lamont RJ. 2008. Role of the Clp system in stress tolerance, biofilm formation, and intracellular invasion in Porphyromonas gingivalis. J. Bacteriol. 190:1436-1446.
47. Kannan TR, Musatovova O, Gowda P, Baseman JB. 2008. Characterization of a unique ClpB protein of Mycoplasma pneumoniae and its impact on growth. Infect. Immun. 76:5082-5092.
48. Turner AK, Lovell MA, Hulme SD, Zhang-Barber L, Barrow PA. 1998. Identification of Salmonella typhimurium genes required for colonization of the chicken alimentary tract and for virulence in newly hatched chicks. Infect. Immun. 66:2099-2106.